We are live on
!
Find out more
AACP
Advantage Alpha Capital Partners Portfolio holdings
AUM
$332M
1-Year Est. Return
12.78%
This Fund
S&P 500
This Quarter
Est. Return
+28.22%
1 Year Est. Return
+12.78%
3 Year Est. Return
+79.23%
5 Year Est. Return
+110.24%
10 Year Est. Return
–
AUM
$427M
AUM Growth
+$147M
(+52%)
Cap. Flow
+$72.3M
Cap. Flow
% of AUM
16.92%
Top 10 Holdings %
Top 10 Hldgs %
19.23%
Holding
102
New
11
Increased
55
Reduced
22
Closed
14
Avg Time Held
1.7
quarters
Top 10 Avg Time Held
0.3
quarters
Top 20 Avg Time Held
0.7
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Curtiss-Wright
CW
|
+$9.13M |
| 2 |
Haemonetics
HAE
|
+$7.51M |
| 3 |
LKQ Corp
LKQ
|
+$7.07M |
| 4 |
Sensata Technologies
ST
|
+$6.7M |
| 5 |
Charles River Laboratories
CRL
|
+$5.56M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nordson
NDSN
|
+$5.1M |
| 2 |
Watsco Inc
WSO
|
+$3.5M |
| 3 |
Appian
APPN
|
+$3.39M |
| 4 |
Graco
GGG
|
+$3.14M |
| 5 |
Bio-Techne
TECH
|
+$2.97M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.59% |
| 2 | Industrials | 25.59% |
| 3 | Healthcare | 15.53% |
| 4 | Consumer Discretionary | 9.73% |
| 5 | Financials | 7.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Haemonetics
HAE
$5.54B
| $8.97M | 2.1% |
100,170
+74,352
| +288% | +$7.51M |
2020 Q1
1 quarter
|
|
|
2
Curtiss-Wright
CW
$18.5B
| $8.56M | 2% |
+95,839
| New | +$9.13M |
2020 Q2
0 quarters
|
|
|
STMP
3
DELISTED
Stamps.com, Inc.
STMP
| $8.46M | 1.98% |
46,052
+14,911
| +48% | +$2.55M |
2019 Q4
2 quarters
|
|
|
NATI
4
DELISTED
National Instruments Corp
NATI
| $8.29M | 1.94% |
214,048
+38,176
| +22% | +$1.44M |
2019 Q4
2 quarters
|
|
|
RP
5
DELISTED
RealPage, Inc.
RP
| $8.26M | 1.93% |
127,093
+43,499
| +52% | +$2.74M |
2019 Q4
2 quarters
|
|
6
Encompass Health
EHC
$12.3B
| $8.21M | 1.92% |
166,545
+78,549
| +89% | +$4.24M |
2019 Q4
2 quarters
|
|
|
FLIR
7
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $7.99M | 1.87% |
197,024
+67,533
| +52% | +$2.8M |
2019 Q4
2 quarters
|
|
|
COUP
8
DELISTED
Coupa Software Incorporated
COUP
| $7.95M | 1.86% |
28,701
-5,122
| -15% | -$1.03M |
2019 Q4
2 quarters
|
|
9
BlackLine
BL
$1.72B
| $7.75M | 1.81% |
93,503
+39,249
| +72% | +$2.62M |
2019 Q4
2 quarters
|
|
10
LiveRamp
RAMP
$2.29B
| $7.69M | 1.8% |
181,054
+30,296
| +20% | +$1.19M |
2019 Q4
2 quarters
|
|
11
Darling Ingredients
DAR
$9.96B
| $7.67M | 1.8% |
311,607
+139,158
| +81% | +$3.03M |
2019 Q4
2 quarters
|
|
12
RB Global
RBA
$16.3B
| $7.65M | 1.79% |
187,265
+26,299
| +16% | +$1.08M |
2019 Q4
2 quarters
|
|
13
Carter's
CRI
$1.17B
| $7.54M | 1.77% |
93,438
+36,056
| +63% | +$2.87M |
2019 Q4
2 quarters
|
|
|
14
LKQ Corp
LKQ
$5.61B
| $7.53M | 1.76% |
+287,216
| New | +$7.07M |
2020 Q2
0 quarters
|
|
|
HMSY
15
DELISTED
HMS Holdings Corp.
HMSY
| $7.09M | 1.66% |
218,944
-12,855
| -6% | -$372K |
2019 Q4
2 quarters
|
|
|
16
Sensata Technologies
ST
$6.19B
| $7.05M | 1.65% |
+189,475
| New | +$6.7M |
2020 Q2
0 quarters
|
|
17
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $6.79M | 1.59% |
49,059
+3,992
| +9% | +$519K |
2019 Q4
2 quarters
|
|
18
MSC Industrial Direct
MSM
$7.38B
| $6.48M | 1.52% |
89,032
+39,578
| +80% | +$2.55M |
2019 Q4
2 quarters
|
|
|
FOCS
19
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $6.44M | 1.51% |
194,727
+61,336
| +46% | +$1.53M |
2019 Q4
2 quarters
|
|
20
HealthEquity
HQY
$7.46B
| $6.2M | 1.45% |
105,598
+26,344
| +33% | +$1.46M |
2019 Q4
2 quarters
|
|
21
Littelfuse
LFUS
$10.5B
| $6.15M | 1.44% |
36,035
+932
| +3% | +$141K |
2019 Q4
2 quarters
|
|
22
WEX
WEX
$5.95B
| $6.1M | 1.43% |
36,970
+21,428
| +138% | +$2.94M |
2019 Q4
2 quarters
|
|
|
23
Charles River Laboratories
CRL
$14.3B
| $6.07M | 1.42% |
+34,826
| New | +$5.56M |
2020 Q2
0 quarters
|
|
24
Kirby Corp
KEX
$7.22B
| $6M | 1.41% |
112,074
+5,891
| +6% | +$301K |
2019 Q4
2 quarters
|
|
25
Zurn Elkay Water Solutions
ZWS
$7.83B
| $5.95M | 1.39% |
423,446
+82,594
| +24% | +$1.08M |
2019 Q4
2 quarters
|
|
Similar funds
CPA
PAWA
EE
GB
SC
SFG
PA
BCCM
Advantage Alpha Capital Partners's Q2 2020 Portfolio in Review
As of Q2 2020, Advantage Alpha Capital Partners held 102 positions worth $427M, up 52% from $281M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Advantage Alpha Capital Partners deployed $72.3M of net new capital in Q2 2020, opening 11 new positions and adding to 55 existing holdings. Its largest new stake was Curtiss-Wright: 95,839 shares worth $8.56M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Bio-Techne, an estimated $2.97M trimmed.
- Advantage Alpha Capital Partners's largest Q2 2020 buy was Curtiss-Wright: 95,839 shares worth $8.56M.
- Advantage Alpha Capital Partners added most to Haemonetics in Q2 2020, an estimated $7.51M increase.
- Advantage Alpha Capital Partners's biggest Q2 2020 reduction was Bio-Techne, cutting an estimated $2.97M.
- Advantage Alpha Capital Partners fully exited Nordson in Q2 2020, selling an estimated $5.1M.
- Advantage Alpha Capital Partners's ten largest holdings make up 19% of its $427M portfolio in Q2 2020.
- Advantage Alpha Capital Partners opened 11 new positions and closed 14 in Q2 2020.
- Advantage Alpha Capital Partners's portfolio value rose 52% quarter-over-quarter to $427M.
Based on Advantage Alpha Capital Partners's 13F filing for Q2 2020, filed 13 Aug 2020.